Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL (Tables)

v3.24.2.u1
SHARE CAPITAL (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

  

   

June 30, 2024

   

June 30, 2023

 
Warrants     13,825,979       270,762  
Options     61,712       26,779  
Convertible debentures     33,332,440       905,011  
Total anti-dilutive weighted average shares     47,220,131       1,202,552